Which drug is best for a patient with type 2 diabetes and heart failure?

被引：1
|
作者：
Clawson, Rebecca [1 ]
Weidman-Evans, Emily [1 ]
Fort, Ashley [1 ]
机构：
[1] LSUHSC Sch Allied Hlth Shreveport, Shreveport, LA USA
来源：
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2021年 / 34卷 / 07期
关键词：
diabetes; heart failure; SGLT-2; inhibitors; HFrEF; thiazolidinediones; metformin; CARDIOVASCULAR OUTCOMES; METFORMIN; MELLITUS; MORTALITY; DISEASE;
D O I：
10.1097/01.JAA.0000743004.83284.cc
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Heart failure is twice as common in men with type 2 diabetes than those without it and is almost five times greater in women with diabetes. Ideally, effective treatment for one condition also will help with the other; certainly, clinicians should not prescribe a medication that will potentially worsen one of the conditions, if avoiding it is at all possible. This article reviews the effects of diabetes medications on heart failure outcomes.
引用
收藏
页码：49 / 52
页数：4
相关论文
共 50 条
  • [1] Management of Type 2 Diabetes in Stage C Heart Failure with Reduced Ejection Fraction
    Agarwalla, Anjali
    Gruen, Jadry
    Peters, Carli
    Sinnenberg, Lauren
    Owens, Anjali T.
    Reza, Nosheen
    CARDIAC FAILURE REVIEW, 2022, 8
  • [2] Treating heart failure in patients with diabetes: The view of the cardiologist
    Kumowski, Nina
    Marx, Nikolaus
    Schuett, Katharina
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 176
  • [3] Type 2 diabetes mellitus and heart failure
    Choy, Christine K.
    Rodgers, Jo E.
    Nappi, Jean M.
    Haines, Stuart T.
    PHARMACOTHERAPY, 2008, 28 (02): : 170 - 192
  • [4] What's new in heart failure in the patient with type 2 diabetes?
    Camafort, Miguel
    ENDOCRINOLOGIA Y NUTRICION, 2015, 62 (07): : 350 - 355
  • [5] Acute vs cumulative benefits of metformin use in patients with type 2 diabetes and heart failure
    Weir, Daniala L.
    Abrahamowicz, Michal
    Beauchamp, Marie-Eve
    Eurich, Dean T.
    DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2653 - 2660
  • [6] Heart failure and diabetes: Clinical significance and epidemiology of this two-way association
    Jerkins, Terri
    McGill, Janet B. B.
    Bell, David S. H.
    DIABETES OBESITY & METABOLISM, 2023, 25 : 3 - 14
  • [7] Management of patients with chronic heart failure and type 2 diabetes mellitus: the SCODIAC-II study
    De Luca, Mariarosaria
    Bosso, Giorgio
    Valvano, Antonio
    Guardasole, Vincenzo
    Botta, Amodio
    Carbone, Vincenzo
    Carella, Giovanni
    Del Buono, Andrea
    Di Giovanni, Giuseppe
    Fimiani, Biagio
    Guarnaccia, Franco
    Lapice, Emanuela
    Martedi, Emilia
    Memoli, Giuseppe
    Oliva, Domenica
    Romano, Geremia
    Cittadini, Antonio
    Zito, Giovanni Battista
    Oliviero, Ugo
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (04) : 895 - 903
  • [8] TYPE 2 DIABETES MELLITUS AND HEART FAILURE: INNOVATIVE POSSIBILITIES FOR MANAGEMENT OF PROGNOSIS
    Kobalava, Zh D.
    Yeshniyazov, N. B.
    Medovchshikov, V. V.
    Khasanova, E. R.
    KARDIOLOGIYA, 2019, 59 (04) : 76 - 87
  • [9] Thiazolidinedione use in elderly patients with type 2 diabetes: with and without heart failure
    Seong, Jong-Mi
    Choi, Nam-Kyong
    Jung, Sun-Young
    Chang, Yoosoo
    Kim, Ye-Jee
    Lee, Joongyub
    Park, Byung-Joo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (04) : 344 - 350
  • [10] Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
    Tseng, Chin-Hsiao
    ONCOTARGET, 2016, 7 (38) : 62687 - 62696
12345